MBRX - 1.70 Pre-market now at 1.80/1.87 Moleculin Biotech Gains 9%, Starts Preclinical Toxicology Testing of WP1732, Plans to Meet FDA Submission Requirements Before Yr-End http://stockcharts.com/c-sc/sc?s=MBRX&p=D&b=5&g=0&i=t02310663116&r=1531916137099